UF discovery could lead to earlier pancreatic cancer treatments
UF College of Pharmacy researchers identified two small molecules that inhibit precancerous cell progression in pancreatic cancer.
UF College of Pharmacy researchers identified two small molecules that inhibit precancerous cell progression in pancreatic cancer.
The American Association for the Advancement of Science is the world’s largest general scientific society.
The Florida-California Cancer Research, Education and Engagement Health Equity Center will be an interdisciplinary, intercollegiate effort involving researchers from the UF College of Pharmacy.
V. Ravi Chandran established the professorship in 2000 to promote creative scientific projects, teaching and fellowships at UF.
Schmittgen has served as a professor of pharmaceutics in the UF College of Pharmacy since 2015 and will lead a highly-productive department of 10 faculty members.
The American Association of Pharmaceutical Scientists has elected Thomas Schmittgen, Ph.D., a professor of pharmaceutics, as one of its 2016 Fellows.
Dr. Thomas Schmittgen is identifying novel treatments and new ways to deliver those therapies by restoring microRNA levels in cancer cells in hopes of finding options for people with the disease.